Edition:
United Kingdom

Insider Trading: Amedisys Inc (AMED.OQ)

AMED.OQ on NASDAQ Stock Exchange Global Select Market

118.93USD
7:50pm BST
Change (% chg)

$-2.58 (-2.12%)
Prev Close
$121.51
Open
$122.43
Day's High
$123.11
Day's Low
$118.93
Volume
38,220
Avg. Vol
195,089
52-wk High
$140.91
52-wk Low
$84.50

All Insider Trades
Trading Date Name Title Type Shares Traded Price
13 Jun 2019

Netterville (Jake L)

Director Sell 1,863 $118.17
10 Jun 2019

Kemmerly (David L.)

General Counsel Buy 3,125 $27.35
10 Jun 2019

Rideout (Jeffrey A M.D.)

Director Sell 900 $116.52
10 Jun 2019

Kemmerly (David L.)

General Counsel Buy 3,125 $27.35
10 Jun 2019

Rideout (Jeffrey A M.D.)

Director Sell 1,494 $117.18
10 Jun 2019

Ginn (Scott G)

Chief Financial Officer Sell 4,872 $118.50
10 Jun 2019

Kemmerly (David L.)

General Counsel Buy 1,875 $27.35
10 Jun 2019

Kemmerly (David L.)

General Counsel Sell 8,125 $117.77
7 Jun 2019

Klapstein (Julie D)

Director Buy 1,297 $0.00
7 Jun 2019

Netterville (Jake L)

Director Buy 1,297 $0.00
7 Jun 2019

Perkins (Bruce D)

Director Buy 1,297 $0.00
7 Jun 2019

Washburn (Donald Arthur)

Director Buy 1,297 $0.00
7 Jun 2019

Rideout (Jeffrey A M.D.)

Director Buy 1,297 $0.00
7 Jun 2019

Rideout (Jeffrey A M.D.)

Director Sell 1,263 $114.33
7 Jun 2019

Lechleiter (Richard A)

Director Buy 1,297 $0.00
6 Jun 2019

Kemmerly (David L.)

General Counsel Sell 4,420 $113.40
5 Jun 2019

North (Michael Paul)

Chief Technology Officer Sell 5,248 $115.01
4 Jun 2019

Ginn (Scott G)

Chief Financial Officer Sell 282 $113.49
4 Jun 2019

North (Michael Paul)

Chief Technology Officer Sell 734 $113.49
4 Jun 2019

Kemmerly (David L.)

General Counsel Sell 411 $113.49
4 Jun 2019

Kemmerly (David L.)

General Counsel Sell 1,640 $113.49
4 Jun 2019

Ginn (Scott G)

Chief Financial Officer Sell 282 $113.49
4 Jun 2019

Ginn (Scott G)

Chief Financial Officer Sell 1,125 $113.49
4 Jun 2019

Ginn (Scott G)

Chief Financial Officer Buy 2,500 $0.00
4 Jun 2019

North (Michael Paul)

Chief Technology Officer Sell 489 $113.49

Institutional Holders

% Shares Owned: 89.26%
# of Holders: 432
Total Shares Held: 28,603,475
3 Mo. Net Change: -1,163,541
# New Positions: 75
# Closed Positions: 51
# Increased Positions: 220
# Reduced Positions: 189
# Net Buyers: 31

Officers & Directors

Name Age Since Current Position

Donald Washburn

74 2014 Non-Executive Lead Independent Chairman of the Board

Paul Kusserow

56 2014 President, Chief Executive Officer, Director

Scott Ginn

49 2017 Chief Financial Officer, Chief Accounting Officer

Christopher Gerard

51 2017 Chief Operating Officer

Sharon Brunecz

2018 Chief Human Resource Officer

Michael North

53 2016 Chief Information Officer

David Pearce

57 2016 Chief Compliance Officer

David Kemmerly

55 2015 General Counsel

Susan Sender

56 2016 Chief Clinical Operations Officer

Julie Klapstein

63 2016 Independent Director

Richard Lechleiter

60 2016 Independent Director

Jake Netterville

80 1997 Independent Director

Bruce Perkins

64 2015 Independent Director

Jeffrey Rideout

56 2016 Independent Director

Nathaniel Zilkha

42 2014 Independent Director

David Castille

2013 IR Contact Officer, Director, Treasury/Finance